vs
Side-by-side financial comparison of ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $158.8M, roughly 1.1× ESSENTIAL PROPERTIES REALTY TRUST, INC.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 22.8%). Over the past eight quarters, ESSENTIAL PROPERTIES REALTY TRUST, INC.'s revenue compounded faster (20.6% CAGR vs 10.6%).
Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
EPRT vs ESPR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.8M | $168.4M |
| Net Profit | $60.0M | — |
| Gross Margin | — | — |
| Operating Margin | 56.5% | 50.6% |
| Net Margin | 37.8% | — |
| Revenue YoY | 22.8% | 143.7% |
| Net Profit YoY | 6.5% | — |
| EPS (diluted) | $0.28 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $158.8M | — | ||
| Q4 25 | $149.9M | $168.4M | ||
| Q3 25 | $144.9M | $87.3M | ||
| Q2 25 | $137.1M | $82.4M | ||
| Q1 25 | $129.4M | $65.0M | ||
| Q4 24 | $119.7M | $69.1M | ||
| Q3 24 | $117.1M | $51.6M | ||
| Q2 24 | $109.3M | $73.8M |
| Q1 26 | $60.0M | — | ||
| Q4 25 | $68.1M | — | ||
| Q3 25 | $65.6M | $-31.3M | ||
| Q2 25 | $63.2M | $-12.7M | ||
| Q1 25 | $56.1M | $-40.5M | ||
| Q4 24 | $55.4M | — | ||
| Q3 24 | $49.1M | $-29.5M | ||
| Q2 24 | $51.5M | $-61.9M |
| Q1 26 | 56.5% | — | ||
| Q4 25 | 65.9% | 50.6% | ||
| Q3 25 | 64.7% | -11.4% | ||
| Q2 25 | 64.1% | 8.6% | ||
| Q1 25 | 61.6% | -34.0% | ||
| Q4 24 | 66.1% | -6.4% | ||
| Q3 24 | 59.7% | -31.0% | ||
| Q2 24 | 61.1% | 3.5% |
| Q1 26 | 37.8% | — | ||
| Q4 25 | 45.4% | — | ||
| Q3 25 | 45.3% | -35.9% | ||
| Q2 25 | 46.1% | -15.4% | ||
| Q1 25 | 43.4% | -62.2% | ||
| Q4 24 | 46.3% | — | ||
| Q3 24 | 42.0% | -57.2% | ||
| Q2 24 | 47.1% | -83.9% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.34 | $0.32 | ||
| Q3 25 | $0.33 | $-0.16 | ||
| Q2 25 | $0.32 | $-0.06 | ||
| Q1 25 | $0.29 | $-0.21 | ||
| Q4 24 | $0.31 | $-0.14 | ||
| Q3 24 | $0.27 | $-0.15 | ||
| Q2 24 | $0.29 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.2M | $167.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.4B | $-302.0M |
| Total Assets | $7.2B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $15.2M | — | ||
| Q4 25 | $60.2M | $167.9M | ||
| Q3 25 | $23.8M | $92.4M | ||
| Q2 25 | $20.8M | $86.1M | ||
| Q1 25 | $47.0M | $114.6M | ||
| Q4 24 | $40.7M | $144.8M | ||
| Q3 24 | $32.7M | $144.7M | ||
| Q2 24 | $23.6M | $189.3M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $1.9B | — |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $4.2B | $-302.0M | ||
| Q3 25 | $3.8B | $-451.4M | ||
| Q2 25 | $3.8B | $-433.5M | ||
| Q1 25 | $3.8B | $-426.2M | ||
| Q4 24 | $3.6B | $-388.7M | ||
| Q3 24 | $3.2B | $-370.2M | ||
| Q2 24 | $3.2B | $-344.2M |
| Q1 26 | $7.2B | — | ||
| Q4 25 | $6.9B | $465.9M | ||
| Q3 25 | $6.6B | $364.0M | ||
| Q2 25 | $6.3B | $347.1M | ||
| Q1 25 | $6.1B | $324.0M | ||
| Q4 24 | $5.8B | $343.8M | ||
| Q3 24 | $5.5B | $314.1M | ||
| Q2 24 | $5.3B | $352.3M |
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.59× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $45.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $381.1M | $45.2M | ||
| Q3 25 | $99.0M | $-4.3M | ||
| Q2 25 | $99.8M | $-31.4M | ||
| Q1 25 | $77.2M | $-22.6M | ||
| Q4 24 | $308.5M | $-35.0M | ||
| Q3 24 | $73.5M | $-35.3M | ||
| Q2 24 | $81.1M | $-7.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-35.5M | ||
| Q2 24 | — | $-7.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -68.7% | ||
| Q2 24 | — | -9.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 5.60× | — | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 1.38× | — | ||
| Q4 24 | 5.57× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
